Drugs / IPV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02847026 Comparator | Sep 2016 → May 2017 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02847026 ↗ |
| Modality | Vaccine | “inactivated poliovirus vaccine (IPV; 0.5 mL, full-dose)” NCT02847026 ↗ |
| Route | Intramuscular | “IPV was administered by needle-syringe as an intramuscular full dose (0·5 mL)” PMID 31104832 ↗ May 2019 |